Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation

The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management a concomitant CAD and its effect on procedural outcomes remain unclear. We evaluate impact revealed during workup percutaneous intervention (PCI) TAVI procedures. A retrospective study was conducted 1336 consecutive patients who underwent Toulouse University Hospital, Rangueil, France. studied population divided into 2 groups: CAD-TAVI group No group. Then, segregated subgroups: PCI-TAVI In-hospital adverse clinical were assessed each Pre-TAVI significant 36% 1030 eligible inclusion study. overall in-hospital death, stroke, major or life threatening bleeding, minor vascular complications, pacemaker implantation, acute kidney injury 2.7%, 2.4%, 2.8%, 3.6%, 3.9%, 7.5%, 12.5%, respectively. Among population, 55% admitted to cardiac care unit. statistical difference observed between groups. Patients with diagnosed pre-TAVI not more likely develop post-TAVI procedure. Also, no mortality observed. In parallel, performing PCI did increase risk death complications. terms distribution antithrombotic regimen may explain higher non bleeding events